A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public reimbursement of medication is often partial to non-existent, particularly in the outpatient setting.
In this video Emerging Markets Director Marc Yates discusses the opportunities and challenges for pharma in self-pay markets and outlines what these mean for healthcare market research.
Registered in England & Wales No. 3350410 as the Research Partnership Limited
Registered office: 2nd Floor, 168 Shoreditch High Street, London, E1 6RA
VAT No. GB 714 0707 65